The regional development of benzodiazepine-binding sites in fetal brain was studied by autoradiography. Cryostat sections through the brains of fetuses from time-pregnant rats were incubated either with r3H]flunitrazepam or with the specific benzodiazepine antagonist [3H]R015-1788. The specificity of radioligand binding was checked by co-incubation with an excess of nonradioactive antagonist or clonazepam, respectively.
Alterations in the behavior of offspring after prenatal exposure to psychoactive substances are of growing interest. Treatment of pregnant rats with high doses of benzodiazepines (BDZs) has been reported to affect the development of locomotor activity and of the acoustic startle reflex in the progeny (Kellogg et al., 1980 (Kellogg et al., , 1983 . These changes do not appear to be a consequence of the presence of drug remaining in brain tissue (Kellogg et 1983; Simmons et al., 1983) . Early postnatal effects have also been reported in human neonates after prenatal exposure to high doses of BDZ (Cree et al., 1973; Speight, 1977 ; American Academy of Pediatrics: Committee on Drugs, 1982; Kanto, 1982) .
Biochemically, BDZ-binding sites are detectable 8 days before birth in rat brain homogenates (Braestrup and Nielsen, 1978; Mallorga et al., 1980; Regan et al., 1980) ; they reach almost maximal levels just 1 week after birth (Candy and Martin, 1979) . However, these studies did not reveal the precise regional distribution of BDZ-binding sites in the brain during prenatal development. Therefore, autoradiographic investigations were carried out to resolve this problem.
[3H]Flunitrazepam and [3H]
Ro 15-1788, a BDZ agonist and antagonist, respectively, 1478 were used as radioligands. A recent study has revealed that the agonist has an affinity for both receptor and acceptor sites in the brain. The latter are binding sites unrelated to the central effects of BDZ tranquilizers; they are found in the ependyma and choroid plexus and represent part of the BDZ-binding sites in the olfactory bulb. At these sites, r3H]flunitrazepam is displaced by Ro 5-4864, a nontranquilizing BDZ that does not interact with the BDZ receptor. The antagonist (Ro 15-1788) is a ligand only for the receptor-binding sites. BDZ receptors have been localized in nerve terminal regions, some of which are GABAergic (Mohler et al., 1980 .
Our study revealed marked differences between individual brain regions. We found a sequential development of BDZ-binding sites in relation to the maturation of brain structures.
Materials and Methods

Animals
and tissue preparation.
Time-pregnant females were bred in our colony of Zivic Miller/SpragueDawley rats. The animals were kept under a constant light/dark cycle (lights on: 6:00 A.M. to 8:00 P.M.) at 22 + 1°C and had free access to food (NAFAG 850) and water. Females were exposed to experienced males for a limited period of time (2 hr) after the onset of the dark period. Sperm-positive females were considered as pregnant. They were separated from the rest of the breeding colony (two per cage) and their weight gain was observed. Twenty-four hours after the 2-l-n mating period was considered as gestational day (GD) 1. For the receptorbinding studies, pregnant animals were taken at different gestational days (GD 14 to 21) and anesthetized with chloral hydrate (700 mg/kg, s.c.). The uterus was exposed and the fetuses were separated from the fetal membranes. They were immobilized, kept on ice, and perfused immediately through the heart with an ice-cold fixative solution containing 0.1% formaldehyde in phosphatebuffered saline; this treatment does not alter the binding of BDZ in adult rat brain (Young and Kuhar, 1980) . The perfused whole brains or whole bodies (of early gestational age animals) were quickly frozen in isopentane cooled with liquid nitrogen and stored in liquid nitrogen until cut in the cryostat.
Incubation
with radioligands.
For the incubation with radiolabeled ligands, lo-pm sections of fixed tissue were cut on a cryostat (American Optical Corp.) and thawmounted onto pre-cleaned, gelatin-coated slides. The slides were kept at -20°C for several days or weeks until used, conditions which do not alter the binding characteristics of BDZ. at 0 to 4" C for 40 min. Then the slides were washed three times in Tris-HCl buffer, dipped into distilled water, dried in dry ice-cooled nitrogen gas, and stored over a desiccant overnight. The slides subsequently were covered with tritium-sensitive sheet film (LKB Ultrofilm) or with emulsion (Ilford K5)-coated coverslips according to the methods of Palacios et al. (1981) and Young and Kuhar (1979) , respectively. After an exposure time of 10 to 21 days in Kodak X-Omatic cassettes, the films were developed (Figs. 21 and 22 ). Silver grain densities obtained with the agonist appeared to be somewhat higher, especially in tissue of early fetal stages. As in adult rats 12.1 to 12.7 mm). The most striking progress in the development of BDZ agonist-and antagonist-binding sites took place in the fetal CNS between GD 14 and GD 15. Within 24 hours at most, cells of large areas of the fetal brain, with the exception of neocortex, acquired the capacity to bind specifically BDZ agonists and antagonists. Midbrain and ventral diencephalon appeared strongly labeled (Figs. 3 and 4). Weak labeling was also seen in the basal telencephalon, rostral to the preoptic region. At all caudorostral levels from lower brainstem to forebrain, binding was observed mainly in ventral structures. This was especially evident in sagittal sections. At about the level of the diencephalictelencephalic junction, silver grains spread to lateral parts of the diencephalon where, at this stage, the primitive internal capsule is formed by the ascending thalamocortical systems. Labeling was also detected in the basal striatal regions of the GD 15 brain. As a rule, BDZ binding was never observed in matrix zones, that is, proliferating zones, in sagittal sections through the hypothalamus.
GD 16 (CRL: 15.1 mm). In lower brainstem and mesencephalon, the differences in labeling of the ventral and dorsal parts largely disappeared (Figs. 5 to 7). In the ventromedial part of the mesencephalon, where the mesencephalic DA cell complex is expanding rapidly and where the ascending catecholamine CA fiber bundle is where binding was most recent. Here, a distinct ventroalready very prominent (Schlumpf et al., 1980) , the grain dorsal gradient was observed. In the developing striatal density was higher than in the more lateral parts. In the region, binding was absent in the densely packed cells of diencephalon, labeling was still concentrated in the ven-the proliferating ependymal zone of the lateral ventricle, tromedial and ventrolateral parts at all caudocranial with only sparse binding in the subependymal layer. The levels. The telencephalon contained those brain regions majority of silver grains overlay the developing caudate Figs. 8 and 9 ). An increased density was seen ventrolaterally, in an area where the olfactory tubercule and pyriform cortex will be located.
On GD 16 some labeling was also found in the cell layers of the olfactory bulb (Figs. 5 and 7) and, for the first time, in neocortical structures (Figs. 10 and 11) . GD 16 marks the date of arrival of the first neuroblasts to form the cortical plate. This event initiates the separation of the primordial plexiform layer into a superficial and a deep cell population. In the neocortex of GD 16, BDZ binding occurred mainly in the frontoventral parts and was restricted to the most superficial cortical layer which is derived from the primordial plexiform layer.
GD 18 (CRL: 20.9 mm). Between GD 16 and GD 18 the neocortical rim as seen on sagittal sections is expanding rapidly (Fig. 12) . On GD 17 the immature trilaminated cortical structure (Konig et al., 1975 ) is already discernible, becoming clearly evident by GD 18. The three neocortical layers consist of the subpial layer with horizontally oriented cells, the densely packed, vertically oriented cell layer, and a third layer of larger horizontal neurons just above the intermediate zone. The first neocortical synapses are described for the superficial and deep layers on GD 16. BDZ binding to neocortical structures developed between GD 16 and GD 18 within the immature trilaminated cortex where distinct concentrations of silver grains were observed in the superficial and deep layers (Figs. 13 and 14) . Some labelling also occurred within the (intermediate) cortical plate. This pattern stayed the same at all lateromedial levels of the developing neocortex of GD 18. Labeling of the olfactory bulb was greatly increased at this time, compared to GD Vol. 3, No. 7, July 1983 Figure 8. Cresyl violet-stained frontal section through the telencephalon of a GD 16 rat fetus. bg, basal ganglia; Zu, lateral ventricle; n, neocortex. Figure 10 . Note the dense labeling in the septal area (s). In the neocortex (n) the typically bifurcated binding pattern is seen in the prospective layers I and VI. Ultrofii.
16, the exception being the zone around the olfactory ventricle (Figs. 12 and 13 ). In the septum, grain densities were slightly higher than in the striatal region (Fig. 15) . Labeling in the septal area was concentrated in the medial septal nuclei. BDZ binding in the mesencephalon and lower brainstem (Figs. 13 and 14) was quite uniformly distributed at this developmental stage, although there was still a tendency toward higher grain densities in more ventral structures.
No labeling was seen in the matrix and ependymal zones of the GD 18 brain.
GD 21 (CRL: 40.9 mm). Two days before birth, BDZ binding approached an adult-like pattern in those brain regions known to strongly bind BDZ in the adult animal. In the adult rat, highest grain densities are observed in the olfactory bulb, neocortex, globus pallidus, superior and inferior colliculi, hippocampus, amygdala, substantia nigra, cerebellum, and dorsal horn of the spinal cord (Young and Kuhar, 1980; Mijhler and Richards, 1982) . Moderate densities occur in the caudate putamen and brainstem.
The most remarkable development on GD 21 was the pronounced increase in labeling of frontal telencephalic --brain regions, especially the neocortex (Figs. 16 to 18 ). However, in contrast to the adult brain, labeling in lower brainstem regions remained intense. In the trilaminated neocortex on GD 18, binding was essentially restricted to the superficial and deep layers, sparing the cortical plate. On GD 21, these two layers continued to be strongly labeled. In addition, the deeper part of the cortical plate, which in the meantime had become more differentiated (Raedler et al., 1980) , was now also intensely labeled with a distinct gradient from deeper to intermediate zones of the cortical plate. At this stage, numerous BDZ-binding sites were found in the olfactory bulb (Fig. 19) . Moreover, the zone of the inner nuclear layer of the retina (Fig. 20) , which 3 days earlier showed only few silver grains, was now heavily labeled.
Discussion
Receptor-mediated effects represent one possible mode of action of drugs on the fetal nervous system, although other types of cellular interaction may also occur. Binding sites for various classes of centrally active drugs become detectable during fetal life; for example, for opiates (Coyle and Pert, 1976; Kent et al., 1982) , neuroleptics (Lichtensteiger et al., 1982) , P-adrenergic antagonists (Bruinink et al., 1982) , and BDZs (Braestrup and Nielsen, 1978; Mallorga et al., 1980; Regan et al., 1980) . Hence, it seems conceivable that some of the behavioral changes noted in the offspring of rats treated with BDZ during pregnancy resulted from drug actions on BDZ receptors in fetal brain.
Any attempt to understand the changes in brain function generated by prenatal BDZ treatment requires precise information on the development of the corresponding binding sites in individual fetal brain regions. Our autoradiographic observations show that central BDZbinding sites develop in a distinct pattern with a general caudorostral gradient, features that are not evident from previous biochemical reports in which no regional analysis of fetal brain was performed. The appearance of binding sites seems to be related to the stage of maturation of individual brain structures.
BDZ binding was first detected on GD 14, in agreement with the observations of Braestrup and Nielsen (1978) . differentiation processes is especially evident in neocorAt this stage (Fig. 23) , labeling is limited to the spinal tex. Here, GD 16 marks the onset of the formation of the cord and lower brainstem, with the highest density in the cortical plate which is accompanied by the separation of ventral marginal zone. In studies on mouse brain, this the primordial plexiform layer into a superficial and deep area has been found to be the site of the first synaptic cell population. These two layers are phylogenetically contracts formed (Vaughn et al., 1977) . A striking spread older and ontogenetically more advanced than the corof BDZ-binding sites occurs between GD 14 and GD 15, tical plate; they contain the first synapses (Konig et al., when binding sites appear in diencephalic and basal 1975) . At the GD 16 stage, BDZ binding was found only telencephalic areas. That BDZ-binding sites are situated in the frontoventral part of neocortex, almost exclusively in differentiating zones is again evident; labeling has in the superficial layer. Binding sites spread over the never been seen in the matrix zones. The ventrodorsal remaining neocortical areas by GD 18, but they remain gradient of neuronal differentiation described, e.g., for restricted to the layers above and below the cortical the diencephalon (Eitschberger, 1970) , is reflected by the plate. When at a later stage (GD al), the layers derived higher density of silver grains in ventral areas of this part from the cortical plate become labeled, the density graof the brain as well as of other regions. The link with dient of silver grains within the cortical plate corresponds This labeling is not visible in an adjacent section (Fig. 22 ) incubated in addition with 1 pM nonradioactive clonazepam. Darkfield optics.
to the inside-out gradient of cell differentiation (Raedler et al., 1980) . Although these observations point to a link between the formation of BDZ-binding sites and nerve cell differentiation, they do not necessarily indicate a relationship to synaptogenesis, despite the fact that BDZ receptors in adult rat brain have been shown to be localized in synaptic regions. In recent studies on postnatal rat cerebellum, the developmental pattern of BDZbinding sites could not be associated with the formation of GABAergic synapses (Palacios and Kuhar, 1982) . Moreover, Chisholm and co-workers (1983) have examined the development of BDZ binding of the triazolopyridazine high and low affinity type in rat cortex, hippocampus, and cerebellum. They observed that the hippocampus, in contrast to the other two regions, contained high affinity binding at birth prior to the periods of dendritic elaboration and synaptogenesis. The specificity of the sites labeled in our autoradiographs has been assessed for both radiolabeled ligands by displacement studies. It is further corroborated by the observation that the labeling pattern was virtually identical for FNZP and the specific BDZ antagonist Ro 15-1788 (Darragh et al., 1981; Hunkeler et al., 1981) . Biochemical studies indicate that the affinity characteristics of BDZ-binding sites do not noticeably change during ontogeny (Braestrup and Nielsen, 1978; Mallorga et al., 1980; Aldinio et al., 1981) . Whether there are changes in the relationship to the GABA receptor remains uncertain. Data on the effect of GABA on BDZ binding during development are contradictory (Palacios et al., 1979; Gallager et al., 1980; Mallorga et al., 1980; Massotti et al., 1980; Regan et al., 1980) . Further information may come from studies on ontogenetic patterns of GABAergic binding sites (Coyle and Enna, 1976; Coyle, 1977) which are presently under way.
The mechanism by which BDZs might affect offspring behavior remains unknown. When given to pregnant dams, BDZs do not appear to cause persistent changes in the number or affinity of binding sites (Braestrup et al., 1979; Kellogg et al., 1983) . Changes in GABA-induced binding were observed, but only after treatment of dams with very high doses (Massotti et al., 1980) . These observations do not seem to exclude a receptor-mediated action of BDZ on fetal brain but, rather, suggest some difference in receptor regulation. The absence of persistent changes in BDZ-binding sites contrasts with data on neuroleptic receptors, which are down-regulated by chronic neuroleptic treatment during pregnancy (Rosengarten and Friedhoff, 1979) .
Some developmental effects of BDZ might be mediated by actions on transmitter systems, since it is known that neurotransmitters influence cell proliferation and differentiation. Indeed, Kellogg and co-workers (1982) noted a 30% reduction in hypothalamic norepinephrine after prenatal BDZ treatment. The development of ascending catecholamine innervation of the forebrain (Schlumpf et al., 1980) and the developmental pattern of BDZ-binding sites follow a similar pattern and time course.
The distinct developmental pattern of BDZ-binding sites might result in differences in the sensitivity of individual brain regions for this class of drugs at different stages of pregnancy. The relatively strong labeling of structures belonging to sensory systems, such as the eye and the olfactory bulb, should also be emphasized. It remains to be elucidated whether there exist critical periods for the various functional disturbances reported after prenatal BDZ treatment. So far, the drug has always been administered to pregnant rats over periods which comprise all the various developmental stages investigated by the present study. Whether these effects of high doses are mediated by BDZ receptors or are nonspecific remains to be elucidated.
